Skip to Content

Cotinga Pharmaceuticals Inc COTQF

Morningstar Rating
$0.00 0.00 (900.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

COTQF is trading at a 16% discount.
Price
$0.00
Fair Value
$5.66
Uncertainty
Extreme
1-Star Price
$6.96
5-Star Price
$3.58
Economic Moat
Nrqvqk
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if COTQF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$2,198.64
Volume/Avg
6,500 / 6,500

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
6

Valuation

Metric
COTQF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
COTQF
Quick Ratio
0.01
Current Ratio
0.05
Interest Coverage
−97.21
Quick Ratio
COTQF

Profitability

Metric
COTQF
Return on Assets (Normalized)
−213.37%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
COTQF
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRWrj$550.2 Bil
VRTX
Vertex Pharmaceuticals IncPbbtc$111.1 Bil
REGN
Regeneron Pharmaceuticals IncRzfvqr$107.7 Bil
MRNA
Moderna IncZlbt$36.9 Bil
ARGX
argenx SE ADRMqgl$24.2 Bil
BNTX
BioNTech SE ADRXjtl$22.3 Bil
ALNY
Alnylam Pharmaceuticals IncHtrhqz$19.9 Bil
BMRN
Biomarin Pharmaceutical IncQdyxjl$17.2 Bil
RPRX
Royalty Pharma PLC Class ARdphn$13.9 Bil
INCY
Incyte CorpRmvyklk$13.6 Bil

Sponsor Center